PURPOSE: In ageing animals, exposure to chronic high levels of glucocorticoids is associated with cognitive impairment and hippocampal atrophy. However, there are few studies examining relationships among glucocorticoids, brain volumes and cognitive function in healthy older humans. This study examined the hypotheses that higher plasma cortisol levels and altered sensitivity to glucocorticoids are associated with worse cognition and more brain atrophy in elderly men. MATERIALS AND METHODS: Ninety-seven healthy men aged 65-70 had plasma cortisol measured at 09:00, 14:30 h, and post-dexamethasone (0.25mg, 09:00 h), and had dermal sensitivity to glucocorticoids measured. They also underwent cognitive testing, with scores adjusted for estimated prior mental ability, and had MRI measurements of intracranial area (a validated estimate of intracranial capacity), and hippocampus, temporal lobe and frontal lobe volumes. RESULTS: Plasma cortisol levels at 09:00 h were significantly and negatively correlated with a summary General Cognitive Factor accounting for 51% of the variance of cognitive function (rho=-0.22, p=0.035), and specific cognitive tests: delayed paragraph recall (rho=-0.28, p=0.036) and processing speed (rho=-0.23, p=0.026). Regional brain volumes adjusted for intracranial area generally did not correlate with cortisol levels. Tissue glucocorticoid sensitivity did not correlate with any measure of cognition or brain volume. CONCLUSIONS: In healthy older men, higher plasma cortisol levels are associated with worse ageing-related overall cognitive change but not ageing-related brain atrophy.
PURPOSE: In ageing animals, exposure to chronic high levels of glucocorticoids is associated with cognitive impairment and hippocampal atrophy. However, there are few studies examining relationships among glucocorticoids, brain volumes and cognitive function in healthy older humans. This study examined the hypotheses that higher plasma cortisol levels and altered sensitivity to glucocorticoids are associated with worse cognition and more brain atrophy in elderly men. MATERIALS AND METHODS: Ninety-seven healthy men aged 65-70 had plasma cortisol measured at 09:00, 14:30 h, and post-dexamethasone (0.25mg, 09:00 h), and had dermal sensitivity to glucocorticoids measured. They also underwent cognitive testing, with scores adjusted for estimated prior mental ability, and had MRI measurements of intracranial area (a validated estimate of intracranial capacity), and hippocampus, temporal lobe and frontal lobe volumes. RESULTS: Plasma cortisol levels at 09:00 h were significantly and negatively correlated with a summary General Cognitive Factor accounting for 51% of the variance of cognitive function (rho=-0.22, p=0.035), and specific cognitive tests: delayed paragraph recall (rho=-0.28, p=0.036) and processing speed (rho=-0.23, p=0.026). Regional brain volumes adjusted for intracranial area generally did not correlate with cortisol levels. Tissue glucocorticoid sensitivity did not correlate with any measure of cognition or brain volume. CONCLUSIONS: In healthy older men, higher plasma cortisol levels are associated with worse ageing-related overall cognitive change but not ageing-related brain atrophy.
Authors: William S Kremen; Robert C O'Brien; Matthew S Panizzon; Elizabeth Prom-Wormley; Lindon J Eaves; Seth A Eisen; Lisa T Eyler; Richard L Hauger; Christine Fennema-Notestine; Bruce Fischl; Michael D Grant; Dirk H Hellhammer; Amy J Jak; Kristen C Jacobson; Terry L Jernigan; Sonia J Lupien; Michael J Lyons; Sally P Mendoza; Michael C Neale; Larry J Seidman; Heidi W Thermenos; Ming T Tsuang; Anders M Dale; Carol E Franz Journal: Neuroimage Date: 2010-02-13 Impact factor: 6.556
Authors: Andrew Pearson; Annick de Vries; Scott D Middleton; Fiona Gillies; Timothy O White; Ian R Armstrong; Ruth Andrew; Jonathan R Seckl; Alasdair Mj MacLullich Journal: BMC Res Notes Date: 2010-02-08
Authors: T S Kubarych; E C Prom-Wormley; C E Franz; M S Panizzon; A M Dale; B Fischl; L T Eyler; C Fennema-Notestine; M D Grant; R L Hauger; D H Hellhammer; A J Jak; T L Jernigan; S J Lupien; M J Lyons; S P Mendoza; M C Neale; L J Seidman; M T Tsuang; W S Kremen Journal: Genes Brain Behav Date: 2012-05-03 Impact factor: 3.449
Authors: Maria C Norton; Ken R Smith; Truls Østbye; JoAnn T Tschanz; Sarah Schwartz; Chris Corcoran; John C S Breitner; David C Steffens; Ingmar Skoog; Peter V Rabins; Kathleen A Welsh-Bohmer Journal: Am J Geriatr Psychiatry Date: 2011-09 Impact factor: 4.105
Authors: Carol E Franz; Robert C O'Brien; Richard L Hauger; Sally P Mendoza; Matthew S Panizzon; Elizabeth Prom-Wormley; Lindon J Eaves; Kristen Jacobson; Michael J Lyons; Sonia Lupien; Dirk Hellhammer; Hong Xian; William S Kremen Journal: Psychoneuroendocrinology Date: 2011-02-03 Impact factor: 4.905
Authors: Alexis M Stranahan; Thiruma V Arumugam; Roy G Cutler; Kim Lee; Josephine M Egan; Mark P Mattson Journal: Nat Neurosci Date: 2008-02-17 Impact factor: 24.884
Authors: Rebecca M Reynolds; Mark W J Strachan; Javier Labad; Amanda J Lee; Brian M Frier; F Gerald Fowkes; Rory Mitchell; Jonathan R Seckl; Ian J Deary; Brian R Walker; Jackie F Price Journal: Diabetes Care Date: 2010-01-22 Impact factor: 17.152